- Investing Ideas
- /
- French Pharmaceuticals & Biotech Strong Balance Sheet Stocks
French Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED Apr 25, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
21 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALNOV | €0.80 | 6.1% | 37.6% | €56.2m | n/a | PS6.1x | n/a | n/a | ||
SAN | €91.62 | 7.5% | -10.0% | €114.4b | €107.67 | PE25.2x | E17.1% | 4.1% | ||
BOI | €34.30 | 1.8% | -11.0% | €595.5m | €39.60 | PE12.5x | E-0.3% | 3.2% | ||
IPN | €112.30 | 5.6% | 5.2% | €9.3b | €124.76 | PE15x | E5.7% | 1.1% | ||
VIRP | €346.50 | -7.1% | 12.7% | €2.9b | €368.00 | PE23.9x | E11.2% | 0.4% | ||
ALERS | €14.44 | -2.7% | -11.7% | €147.6m | €30.00 | PE30.8x | E36.3% | n/a | ||
DBV | €1.21 | -3.2% | -58.4% | €116.6m | €4.78 | PS8x | E53.3% | n/a | ||
ALCLS | €2.38 | 0.6% | 32.7% | €170.8m | n/a | PS7.5x | E45.9% | n/a | ||
AELIS | €13.00 | 0% | -7.5% | €170.7m | €20.67 | PS13.8x | E-43.4% | n/a | ||
ALSEN | €0.71 | -3.0% | 136.7% | €195.6m | €2.38 | PS35.1x | E42.8% | n/a | ||
ALVET | €0.79 | 7.9% | -68.8% | €2.5m | n/a | PS2x | n/a | n/a | ||
VETO | €98.00 | 3.7% | 12.3% | €1.2b | €108.42 | PE20.9x | E5.0% | 0.9% | ||
GNFT | €3.24 | 1.6% | -4.0% | €160.8m | €9.38 | PS4.7x | E54.7% | n/a | ||
ABVX | €14.74 | 4.4% | 1.8% | €927.4m | €35.74 | PS206.4x | E14.6% | n/a | ||
ALGEN | €3.96 | 0.3% | 2.1% | €35.7m | n/a | PE22.8x | n/a | n/a | ||
MAAT | €9.06 | 1.3% | -3.8% | €105.1m | €15.50 | PS47.2x | E-10.2% | n/a | ||
ALECR | €21,800.00 | 0% | -24.8% | €110.0m | n/a | PE9.5x | n/a | n/a | ||
ERF | €57.50 | -4.3% | -8.9% | €11.1b | €60.00 | PE43.2x | E20.3% | 0.9% | ||
IPH | €2.18 | 1.4% | -15.5% | €176.2m | €6.27 | PS2.9x | E33.0% | n/a | ||
ALNEV | €0.30 | -21.1% | -100.0% | €105.5k | n/a | PS2x | n/a | n/a | ||
TNG | €1.28 | -12.1% | -30.0% | €128.7m | €3.50 | PS16.3x | E-26.1% | n/a |
Page 1 of 1